BDBM163059 US9062004, 25

SMILES CCCNc1cnn(-c2cc(Cl)cc(Cl)c2)c(=O)c1Cl

InChI Key InChIKey=XGTFHIJGWDETSN-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 163059   

TargetCannabinoid receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM163059(US9062004, 25)
Affinity DataIC50: 1.00E+4nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent

TargetCannabinoid receptor 1(Human)
Allergan

US Patent
LigandPNGBDBM163059(US9062004, 25)
Affinity DataIC50: 1.00E+4nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2016
Entry Details
US Patent